Archives of the Turkish Society of Cardiology
COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option? [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2020; 48(7): 631-634 | DOI: 10.5543/tkda.2020.64072

COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?

Selçuk Şen, Ali Yağız Üresin
Department of Medical Pharmacology, Division of Clinical Pharmacology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

Keywords: COVID-19, ACE inhibitor, angiotensin receptor blocker, direct renin inhibitor, aliskiren

How to cite this article
Selçuk Şen, Ali Yağız Üresin. COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?. Turk Kardiyol Dern Ars. 2020; 48(7): 631-634

Corresponding Author: Selçuk Şen, Türkiye
© Copyright 2020 Archives of the Turkish Society of Cardiology
LookUs & Online Makale